Hara Prasad Pati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hara Prasad Pati has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek Purohit
Department of Pathology, All India Institute of Medical Sciences, Jodhpur, India
6 shared publications - Mukul Aggarwal
Department of Hematology, AIIMS, New Delhi, India
6 shared publications - Manoranjan Mahapatra
Department of Hematology, All India Institute of Medical Sciences, New Delhi 110029, India
4 shared publications - Renu Saxena
Department of Hematology, All India Institute of Medical Sciences, New Delhi 110029, India
4 shared publications - Seema Tyagi
Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
4 shared publications - Venkatesan Somasundaram
Department of Pathology, Armed Forces Medical College, Pune, India
4 shared publications
Latest Publications
- Open Access
- 15 July 2015
- Published by Elsevier in Leukemia Research Reports
- Vol. 4 (2) , 76-78
Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy
- 15 July 2015
- Published by Elsevier in Leukemia Research Reports
- Vol. 4 (2) , 76-78
Open AccessUnusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy
- 14 April 2015
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 32 (2) , 197
Erratum to: Re-evaluation of Need for Bone Marrow Examination in Patients with Isolated Thrombocytopenia
[This corrects the article DOI: 10.1007/s12288-015-0533-2.].
- 14 April 2015
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 32 (2) , 197
Erratum to: Re-evaluation of Need for Bone Marrow Examination in Patients with Isolated Thrombocytopenia
[This corrects the article DOI: 10.1007/s12288-015-0533-2.].
- Open Access
- 28 March 2015
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 32 (2) , 193-196
Re-evaluation of Need for Bone Marrow Examination in Patients with Isolated Thrombocytopenia Contributors
Diagnosis of immune thrombocytopenia (ITP) is based on clinical suspicion and normal peripheral smear except for thrombocytopenia. Bone marrow examination is carried out to rule out leukemia, myelodysplastic syndrome or aplastic anemia. However, in most cases, clinical diagnosis is not altered after the bone marrow reports. Hence, this present study was carried out to evaluate the justification for bone marrow examination in the setting of isolated thrombocytopenia. All patients presenting to the hematology OPD with isolated thrombocytopenia and suspected diagnosis of ITP, between October 2011 and April 2013, were included in the study. Data was collected from bone marrow reports and outpatient records. A total of 353 cases were found. 319 cases had features of typical ITP and the rest had some form of organomegaly and/or lymphadenopathy. Bone marrow examination in all cases revealed normal hematopoietic elements and prominence of megakaryocytes including juvenile forms with no novel diagnosis in any patient. Routine use of bone marrow examination in the diagnostic workup of isolated thrombocytopenia is not required in our center even if steroids are planned as a first line therapy. However, a detailed history, thorough examination with complete hemogram and peripheral smear examination are essential.
- 28 March 2015
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 32 (2) , 193-196
Open AccessRe-evaluation of Need for Bone Marrow Examination in Patients with Isolated Thrombocytopenia Contributors
Diagnosis of immune thrombocytopenia (ITP) is based on clinical suspicion and normal peripheral smear except for thrombocytopenia. Bone marrow examination is carried out to rule out leukemia, myelodysplastic syndrome or aplastic anemia. However, in most cases, clinical diagnosis is not altered after the bone marrow reports. Hence, this present study was carried out to evaluate the justification for bone marrow examination in the setting of isolated thrombocytopenia. All patients presenting to the hematology OPD with isolated thrombocytopenia and suspected diagnosis of ITP, between October 2011 and April 2013, were included in the study. Data was collected from bone marrow reports and outpatient records. A total of 353 cases were found. 319 cases had features of typical ITP and the rest had some form of organomegaly and/or lymphadenopathy. Bone marrow examination in all cases revealed normal hematopoietic elements and prominence of megakaryocytes including juvenile forms with no novel diagnosis in any patient. Routine use of bone marrow examination in the diagnostic workup of isolated thrombocytopenia is not required in our center even if steroids are planned as a first line therapy. However, a detailed history, thorough examination with complete hemogram and peripheral smear examination are essential.
- 14 September 2014
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 32 (S1) , 301-303
Priapism Associated with Homozygous Hb E State: A Causal Association or an Incidental Finding?
- 14 September 2014
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 32 (S1) , 301-303
Priapism Associated with Homozygous Hb E State: A Causal Association or an Incidental Finding?
- 17 August 2014
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 30 (S1) , 413-417
Unusual Presentation of Hairy Cell Leukemia: A Case Series of Four Clinically Unsuspected Cases
Hairy cell leukemia (HCL) is characterized by pancytopenia and usually associated with massive splenomegaly, however the same may not be true in the clinical settings. Here we report four cases of HCL and all of them were without the classical clinical feature of splenomegaly. This is an observational study conducted between January 2013 to March 2014 where we could diagnose ten cases of HCL in Department of Hematology, All India Institute of Medical Sciences, New Delhi. Of these, four cases attracted attention because of absence of classical clinical features of HCL. Of the four cases, three presented with weakness/fatigability while fourth patient presented with recurrent respiratory tract infection. Surprising finding in these cases was absence of splenomegaly, both clinically and on imaging which demerit the suspicion of HCL clinically. All four had bi/pancytopenia and bone marrow examination coupled with immunophenotypic analysis confirmed the diagnosis of HCL. Three patients received chemotherapy with cladribine and achieved complete hematological remission. One patient did not receive chemotherapy due to poor general condition and was subsequently lost to follow up. To conclude, HCL can and do present without splenomegaly and this should not restrain one from suspecting HCL based on histomorphology which needs to be further confirmed by ancillary techniques. This finding in our series could be because these cases were picked early in their natural course of the disease. A high index of suspicion is essential for diagnosing and appropriately managing such cases.
- 17 August 2014
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 30 (S1) , 413-417
Unusual Presentation of Hairy Cell Leukemia: A Case Series of Four Clinically Unsuspected Cases
Hairy cell leukemia (HCL) is characterized by pancytopenia and usually associated with massive splenomegaly, however the same may not be true in the clinical settings. Here we report four cases of HCL and all of them were without the classical clinical feature of splenomegaly. This is an observational study conducted between January 2013 to March 2014 where we could diagnose ten cases of HCL in Department of Hematology, All India Institute of Medical Sciences, New Delhi. Of these, four cases attracted attention because of absence of classical clinical features of HCL. Of the four cases, three presented with weakness/fatigability while fourth patient presented with recurrent respiratory tract infection. Surprising finding in these cases was absence of splenomegaly, both clinically and on imaging which demerit the suspicion of HCL clinically. All four had bi/pancytopenia and bone marrow examination coupled with immunophenotypic analysis confirmed the diagnosis of HCL. Three patients received chemotherapy with cladribine and achieved complete hematological remission. One patient did not receive chemotherapy due to poor general condition and was subsequently lost to follow up. To conclude, HCL can and do present without splenomegaly and this should not restrain one from suspecting HCL based on histomorphology which needs to be further confirmed by ancillary techniques. This finding in our series could be because these cases were picked early in their natural course of the disease. A high index of suspicion is essential for diagnosing and appropriately managing such cases.
- 20 July 2014
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 31 (2) , 292-294
Immunophenotypic Aberrancy of a Case of Hairy Cell Leukemia
- 20 July 2014
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 31 (2) , 292-294
Immunophenotypic Aberrancy of a Case of Hairy Cell Leukemia
- 17 April 2003
- Vol. 22 (2) , 59-60
Spectrum of hemostatic derangements, in Budd-Chiari syndrome.
Hemostatic abnormalities have been reported in various hepatocellular diseases. We evaluated the hemostatic functions in patients with Budd-Chiari syndrome. Biochemical liver function tests, and measurement of prothrombin time, activated partial thromboplastin time, and plasma levels of anti-thrombin III (antigen) and activity of protein C were done in 36 patients with Budd-Chiari syndrome. Liver biochemistry was abnormal in 34 patients. Plasma prothrombin time and activated partial thromboplastin time were prolonged in 17 (47%) and 23 (64%) patients, respectively. Antithrombin III antigen levels and protein C activity were reduced in 15 (50%) and 25 (83%) patients, respectively, among the 30 patients studied. Albumin levels showed significant correlation with coagulation test results, levels of anti-thrombin-III, and protein C activity. Hepatic synthesis of coagulation factors and anticoagulants is reduced in Budd-Chiari syndrome; this may play a role in recurrence of thrombosis.
- 17 April 2003
- Vol. 22 (2) , 59-60
Spectrum of hemostatic derangements, in Budd-Chiari syndrome.
Hemostatic abnormalities have been reported in various hepatocellular diseases. We evaluated the hemostatic functions in patients with Budd-Chiari syndrome. Biochemical liver function tests, and measurement of prothrombin time, activated partial thromboplastin time, and plasma levels of anti-thrombin III (antigen) and activity of protein C were done in 36 patients with Budd-Chiari syndrome. Liver biochemistry was abnormal in 34 patients. Plasma prothrombin time and activated partial thromboplastin time were prolonged in 17 (47%) and 23 (64%) patients, respectively. Antithrombin III antigen levels and protein C activity were reduced in 15 (50%) and 25 (83%) patients, respectively, among the 30 patients studied. Albumin levels showed significant correlation with coagulation test results, levels of anti-thrombin-III, and protein C activity. Hepatic synthesis of coagulation factors and anticoagulants is reduced in Budd-Chiari syndrome; this may play a role in recurrence of thrombosis.